Abstract:
Synthesis of polyionenes with built-in degradable linkers through addition polymerization of a novel class of degradable A2-type monomers (d-A2), and their use as antimicrobial agents are disclosed. A library of biodegradable polyionenes and Gemini-surfactants made from d-A2 monomers are also disclosed. These materials have potent and broad spectrum of antimicrobial activity with high selectivity over mammalian cells.
Abstract:
A method for synthesizing a derivative of a saccharide such as starch, substituted with quaternary ammonium cations, forming a cationic polysaccharide. The method comprises subjecting a saccharide to a mixture of an optionally substituted halo-epoxide such as epichlorohydrin and one or more optionally substituted amines. The method may be prepared in a one-pot synthesis via the formation of a glycidyl derivative of a tertiary amine as an in situ intermediate. The starch polymers formed are biodegradable, have antimicrobial properties and can be further formed into antimicrobial hydrogels by photo-crosslinking of the starch derivative.
Abstract:
Disclosed herein is a compound of structure (A): In this compound, X is either O or S, R 1 is a rigid group, R 2 is a hydrophilic group such that (A) is capable of self-assembly in water, and R 3 is an organic group.
Abstract:
The present invention relates to polycarbonate-based diblock polymers, nanoparticles comprising the diblock polymers and a therapeutic agent, in particular the therapeutic agent is attached to a magnetic moiety, and methods to prepare the diblock polymers and nanoparticles. Said diblock polymer comprises: (i) a first block polymer comprising of a polyether repeating unit; and (ii) a second block polymer comprising of a repeating unit of a general Formula I wherein (a) R 1 , R 2 , R 3 , R 4 , and R 5 is each independently selected from the group comprising: hydrogen, halogen, alkyl group comprising 1 to 20 carbon atoms, and aryl group comprising 6 to 20 carbon atoms, (b) p and q is each independently an integer from 0 to 6, wherein p and q cannot both be 0, (c) A is a linker, and (d) B is an aromatic moiety with two adjacent hydroxyl groups, for example catechol moiety. In a preferred embodiment, the nanoparticles encapsulated with iron-salen complexed paclitaxel are formed for use in breast cancer treatment.
Abstract:
An antimicrobial composition comprises an anionic drug and an amine polymer comprising a first repeat unit of formula (2); wherein a' is an integer equal to 1 or 2, b' is an integer equal to 1 or 2, and each R' is an independent monovalent radical selected from the group consisting of hydrogen, methyl, ethyl, and combinations thereof. G' is a divalent linking group selected from the group consisting of a single bond and groups comprising at least one carbon. X¯ is a negatively charged counterion. The drug and the amine polymer are bound by noncovalent interactions.
Abstract:
This invention relates to an antibacterial polymer-modified particle comprising a particle core, wherein a polymer is covalently bound to the particle core via a linker and said polymer comprises a branched, amphiphilic cationic polyalkylene imine backbone having amine or amino functional groups and wherein optionally all or some of the amine or amino groups of the polymer have been further reacted with amphiphilic cyclic carbonates carrying a quaternary ammonium group under formation of a urethane bond. In a preferred embodiment the core is a silica core functionalized with the polyelkyleneimine. The invention also relates to methods of making such particles and their use in water disinfection applications.
Abstract:
A composite hydrogel comprises an amphiphilic triblock copolymer (ABA) and a loaded micelle bound by noncovalent interactions. The loaded micelle comprises a biologically active substance and an amphiphilic diblock copolymer (CD). The A blocks comprise a steroidal repeat unit (repeat unit 1) having both a backbone carbonate and a side chain bearing a steroid functional group. Each of the A blocks has a degree of polymerization of about 0.5 to about 4.0. The B block comprises a first poly(alkylene oxide) backbone. The C block comprises a second poly(alkylene oxide) backbone. The D block comprises a steroidal repeat unit (repeat unit 2) having both a backbone carbonate group and a side chain comprising a steroid functional group. The composite hydrogel is capable of controlled release of the biologically active substance.